ABVC - ABVC Biopharma cools off following meme buzz; shares fall 33%

After a massive 137% rise yesterday, shares of ABVC Biopharma (ABVC -33.1%) have pared some of those gains today. Shares were up 400% premarket yesterday due to strong retail investor interest on the trading social network StockTwits. Volume so far today is ~4.5M shares. Average daily volume is ~3.4M shares. ABVC has six drugs and a medical device called ABV-1701/Vitargus in its pipeline. Earlier this month, ABVC executed a joint venture agreement with Tokyo-based private investment firm Lucidam.

For further details see:

ABVC Biopharma cools off following meme buzz; shares fall 33%